Peromyscus leucopus mice: a potential animal model for haematological studies

Yu Sun1, Marie J Desierto, Yasutaka Ueda

  • 1Hematology Department, 2nd Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Insights

Peromyscus leucopus linville (PLL) mice exhibit distinct hematological profiles compared to Mus musculus, with fewer platelets and more monocytes. These differences suggest PLL mice may serve as a better model for human hematopoiesis.

Area of Science:

  • Comparative hematology
  • Mammalian physiology
  • Biomedical research models

Background:

  • Peromyscus leucopus (PLL) mice possess higher agility and longer lifespans than Mus musculus (MM).
  • Understanding hematological differences is crucial for selecting appropriate animal models in research.

Purpose of the Study:

  • To compare the cellular composition of peripheral blood (PB), bone marrow (BM), and spleen between domesticated PLL and laboratory MM mice.
  • To assess age-related hematological changes and the impact of antioxidant treatment in PLL mice.

Main Methods:

  • Comparative analysis of PB, BM, and spleen cellularity in PLL and MMB6 mice.
  • Age-stratified analysis (2-8 months vs. 16-26 months) of PLL mice.
  • Evaluation of N-acetylcysteine's effect on cellular ROS and hematology in PLL mice.

Main Results:

  • PLL mice showed significantly lower platelets and higher monocytes in PB, and fewer megakaryocytes in BM compared to MMB6.
  • PLL spleens were smaller with reduced cellularity and 'red pulp'.
  • Monocyte counts increased with age in PLL mice; antioxidant treatment did not alter ROS but increased leukocytes and monocytes.

Conclusions:

  • The hematological profile of PLL mice (low platelets, high monocytes, low splenic erythropoiesis) more closely resembles human physiology than MMB6 mice.
  • PLL mice represent a potentially valuable model for studying human hematological conditions.
  • Age and antioxidant intervention have specific, differential effects on PLL hematopoiesis.